E3 Lithium Ltd
XTSX:ETL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E3 Lithium Ltd
XTSX:ETL
|
CA |
|
Harbin Pharmaceutical Group Co Ltd
SSE:600664
|
CN |
|
Q
|
Qliro AB
STO:QLIRO
|
SE |
|
L
|
LTS Inc
TSE:6560
|
JP |
|
Boyd Gaming Corp
NYSE:BYD
|
US |
|
B
|
Beijing Cuiwei Tower Co Ltd
SSE:603123
|
CN |
|
S.F. Holding Co Ltd
SZSE:002352
|
CN |
|
Jiangsu Libert Inc
SSE:605167
|
CN |
Balance Sheet
Balance Sheet Decomposition
E3 Lithium Ltd
E3 Lithium Ltd
Balance Sheet
E3 Lithium Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
0
|
0
|
6
|
18
|
13
|
30
|
19
|
|
| Cash |
0
|
0
|
1
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
18
|
13
|
30
|
19
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Assets |
0
|
0
|
1
|
0
|
1
|
7
|
18
|
19
|
36
|
21
|
|
| PP&E Net |
0
|
0
|
2
|
3
|
3
|
3
|
5
|
13
|
21
|
29
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
3
|
5
|
13
|
21
|
29
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
5
|
5
|
|
| Total Assets |
0
N/A
|
0
+13%
|
3
+14 328%
|
3
+12%
|
4
+54%
|
11
+138%
|
26
+144%
|
36
+39%
|
62
+72%
|
55
-11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+21%
|
0
-34%
|
0
-55%
|
0
+271%
|
1
+19%
|
1
+82%
|
3
+166%
|
5
+84%
|
4
-12%
|
|
| Equity | |||||||||||
| Common Stock |
13
|
13
|
17
|
18
|
20
|
28
|
44
|
53
|
83
|
83
|
|
| Retained Earnings |
14
|
14
|
14
|
18
|
20
|
21
|
27
|
34
|
43
|
52
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
2
|
4
|
3
|
8
|
15
|
17
|
20
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
-22%
|
2
N/A
|
3
+20%
|
4
+44%
|
10
+151%
|
25
+148%
|
33
+34%
|
57
+71%
|
51
-11%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+13%
|
3
+14 328%
|
3
+12%
|
4
+54%
|
11
+138%
|
26
+144%
|
36
+39%
|
62
+72%
|
55
-11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
3
|
3
|
17
|
21
|
27
|
42
|
58
|
63
|
75
|
75
|
|